LIVALO pitavastatin 4 mg film-coated tablet blister pack Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

livalo pitavastatin 4 mg film-coated tablet blister pack

advantage medical products consulting pty ltd - pitavastatin calcium, quantity: 4.18 mg (equivalent: pitavastatin, qty 4 mg) - tablet, film coated - excipient ingredients: aluminium magnesium silicate; lactose monohydrate; hypromellose; triethyl citrate; magnesium stearate; hyprolose; titanium dioxide; colloidal anhydrous silica - livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. prior to initiating therapy with livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

LIVALO pitavastatin 2 mg film-coated tablet blister pack Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

livalo pitavastatin 2 mg film-coated tablet blister pack

advantage medical products consulting pty ltd - pitavastatin calcium, quantity: 2.09 mg (equivalent: pitavastatin, qty 2 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; triethyl citrate; aluminium magnesium silicate; magnesium stearate; lactose monohydrate; hypromellose; titanium dioxide; hyprolose - livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. prior to initiating therapy with livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

LIVALO pitavastatin 1 mg film-coated tablet blister pack Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

livalo pitavastatin 1 mg film-coated tablet blister pack

advantage medical products consulting pty ltd - pitavastatin calcium, quantity: 1.045 mg (equivalent: pitavastatin, qty 1 mg) - tablet, film coated - excipient ingredients: hyprolose; titanium dioxide; triethyl citrate; hypromellose; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; aluminium magnesium silicate - livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. prior to initiating therapy with livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

INACTIVATED AVIAN INFLUENZA VIRUS H7N1 (STRAIN A/CK/ITALY/1067/99) Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

inactivated avian influenza virus h7n1 (strain a/ck/italy/1067/99)

department of agriculture, fisheries and forestry - inactivated avian influenza virus h7n1 (a/ck/italy/1099) - unknown - inactivated avian influenza virus h7n1 (a/ck/italy/1099) vaccine active 0.0 - active constituent

INACTIVATED AVIAN INFLUENZA VIRUS H5N9 (STRAIN A/CK/ITALY/22A/H5N9/1998) Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

inactivated avian influenza virus h5n9 (strain a/ck/italy/22a/h5n9/1998)

department of agriculture, fisheries and forestry - inactivated avian influenza virus h5n9 (strain a/ck/ital - unknown - inactivated avian influenza virus h5n9 (strain a/ck/ital vaccine-viral active 0.0 - active constituent

FEL-O-VAX LV-K VACCINE (INACTIVATED) Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fel-o-vax lv-k vaccine (inactivated)

boehringer ingelheim animal health australia pty. ltd. - amphotericin b; neomycin; polymixin b; feline leukaemia virus - inactivated; thiomersal - misc. vaccines or anti sera - amphotericin b antibiotic active 0.0 undefined; neomycin antibiotic active 0.0 undefined; polymixin b antibiotic active 0.0 undefined; feline leukaemia virus - inactivated vaccine-viral active 0.0 undefined; thiomersal mercury other 0.0 undefined - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | disease caused by

Boostrix Polio – Suspension for injection. Diphtheria, tetanus, pertussis (acellular component) and poliomyelitis (inactivated) vaccine (adsorbed) Малта - Енглески - Medicines Authority

boostrix polio – suspension for injection. diphtheria, tetanus, pertussis (acellular component) and poliomyelitis (inactivated) vaccine (adsorbed)

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection - diphtheria toxoid filamentous haemagglutinin (fha) 8 µg pertactin 2.5 µg pertussis toxoid 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu tetanus toxoid - vaccines